China SXT Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SXTC for the last semiannual is 988.91 k USD, and it's 5.25% higher compared to the previous semiannual. The net income of H2 23 is 6.60 M USD.